No­vo Nordisk ramps up le­gal case against com­pound­ing phar­ma­cies sell­ing 'mis­brand­ed' semaglu­tide

No­vo Nordisk is tak­ing an­oth­er Flori­da phar­ma­cy to court af­ter al­leged­ly find­ing im­pu­ri­ties in its com­pound­ed drugs mar­ket­ed as semaglu­tide, in­clud­ing one sam­ple that was …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER